Amanote Research

Amanote Research

    RegisterSign In

Elagolix: First Global Approval

Drugs - United Kingdom
doi 10.1007/s40265-018-0977-4
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

September 1, 2018

Authors
Yvette N. Lamb
Publisher

Springer Science and Business Media LLC


Related search

Polatuzumab Vedotin: First Global Approval

Drugs
Pharmacology
2019English

Correction To: Ibalizumab: First Global Approval

Drugs
Pharmacology
2018English

Erratum To: Brodalumab: First Global Approval

Drugs
Pharmacology
2016English

Correction To: Delafloxacin: First Global Approval

Drugs
Pharmacology
2018English

Correction To: Camrelizumab: First Global Approval

Drugs
Pharmacology
2019English

Correction To: Polatuzumab Vedotin: First Global Approval

Drugs
Pharmacology
2019English

First Tissue-Agnostic Drug Approval Issued

Cancer Discovery
Oncology
2017English

Oncolytic Viruses Get a Boost With First FDA-approval Recommendation

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2015English

Dinutuximab Combination Therapy Becomes First Approval for High-Risk Neuroblastoma

Journal of Community and Supportive Oncology
OncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy